• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2002 - 2003年德国分离的肺炎链球菌和化脓性链球菌大环内酯类耐药机制的分子特征

Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.

作者信息

Reinert Ralf René, Franken Carmen, van der Linden Mark, Lütticken Rudolf, Cil Murat, Al-Lahham Adnan

机构信息

Institute for Medical Microbiology, National Reference Center for Streptococci, University Hospital, Pauwelsstrasse 30, D-52057 Aachen, Germany.

出版信息

Int J Antimicrob Agents. 2004 Jul;24(1):43-7. doi: 10.1016/j.ijantimicag.2004.02.020.

DOI:10.1016/j.ijantimicag.2004.02.020
PMID:15225860
Abstract

In the present study, a real-time PCR protocol was developed for the detection of macrolide resistance determinants and was validated in a nationwide study in Germany covering a total of 236 Streptococcus pyogenes and 241 Streptococcus pneumoniae strains collected from children < or = 16 years of age with community-acquired infections. Macrolide resistance was observed in 19.9% of pneumococcal strains and 14% of S. pyogenes isolates. Of the erythromycin A-resistant S. pyogenes strains, 93.9% showed the efflux type mef(A); 62.5% of the S. pneumoniae strains were mef(A)- and 37.5% erm(B)-positive. The correlation of the results of real-time PCR assay genotyping in the present study compared with those of conventional PCR genotyping and resistance phenotyping was 100%. Macrolide resistance is of growing concern in Germany. This highly sensitive and specific PCR assay to detect macrolide resistance has the potential to provide sufficiently rapid results to improve antibiotic treatment of streptococcal infections.

摘要

在本研究中,开发了一种用于检测大环内酯类耐药决定因素的实时PCR方法,并在德国一项全国性研究中进行了验证,该研究共纳入了236株化脓性链球菌和241株肺炎链球菌,这些菌株均采集自16岁及以下社区获得性感染儿童。在19.9%的肺炎链球菌菌株和14%的化脓性链球菌分离株中观察到大环内酯类耐药。在对红霉素A耐药的化脓性链球菌菌株中,93.9%表现为外排型mef(A);62.5%的肺炎链球菌菌株mef(A)阳性,37.5%的erm(B)阳性。本研究中实时PCR检测基因分型结果与传统PCR基因分型和耐药表型分析结果的相关性为100%。大环内酯类耐药在德国日益受到关注。这种用于检测大环内酯类耐药的高度灵敏且特异的PCR方法有可能提供足够快速的结果,以改善链球菌感染的抗生素治疗。

相似文献

1
Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.2002 - 2003年德国分离的肺炎链球菌和化脓性链球菌大环内酯类耐药机制的分子特征
Int J Antimicrob Agents. 2004 Jul;24(1):43-7. doi: 10.1016/j.ijantimicag.2004.02.020.
2
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).在加拿大呼吸道病原体药敏试验(CROSS,1998 - 2004年)的6年期间分离出的肺炎链球菌中的大环内酯类耐药机制。
J Antimicrob Chemother. 2007 Oct;60(4):733-40. doi: 10.1093/jac/dkm273. Epub 2007 Aug 2.
3
mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.mef(A) 是德国肺炎链球菌和化脓性链球菌中主要的大环内酯类耐药决定因素。
Int J Antimicrob Agents. 2011 May;37(5):425-31. doi: 10.1016/j.ijantimicag.2011.01.019. Epub 2011 Mar 21.
4
mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.来自挪威的大环内酯类耐药链球菌属分离株中的mef(A)、mef(E)和一种新的mef等位基因。
J Antimicrob Chemother. 2005 Nov;56(5):841-6. doi: 10.1093/jac/dki327. Epub 2005 Sep 19.
5
Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.从呼吸道感染患者中分离出的肺炎链球菌菌株对大环内酯类药物的耐药性及耐药机制在美国的分布情况:2001 - 2002年美国肺炎链球菌耐药性监测研究(PROTEKT US)
J Antimicrob Chemother. 2004 Aug;54 Suppl 1:i17-22. doi: 10.1093/jac/dkh312.
6
Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.土耳其耐红霉素肺炎链球菌中的大环内酯类耐药决定因素
Jpn J Infect Dis. 2008 Nov;61(6):490-3.
7
Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).西班牙巴塞罗那地区成年患者中分离的大环内酯类和多种耐药性酿脓链球菌的分子特征(1993-2008 年)。
J Antimicrob Chemother. 2010 Apr;65(4):634-43. doi: 10.1093/jac/dkq006. Epub 2010 Jan 29.
8
High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.中国从咽炎患儿中分离出的化脓性链球菌菌株对大环内酯类药物具有高耐药性。
Pediatr Pulmonol. 2009 May;44(5):436-41. doi: 10.1002/ppul.20976.
9
Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.韩国大环内酯类耐药肺炎链球菌分离株的荚膜血清型分布及大环内酯类耐药机制
Diagn Microbiol Infect Dis. 2009 Feb;63(2):213-6. doi: 10.1016/j.diagmicrobio.2008.10.002. Epub 2008 Dec 18.
10
Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.从1999 - 2000年PROTEKT研究中分离出的肺炎链球菌和化脓性链球菌大环内酯类耐药机制的分子特征
J Antimicrob Chemother. 2002 Sep;50 Suppl S1:39-47. doi: 10.1093/jac/dkf806.

引用本文的文献

1
Macrolide-resistance, capsular genotyping and associated factors of group B Streptococci colonized pregnant women in Isfahan, Iran.伊朗伊斯法罕地区妊娠妇女中B族链球菌的大环内酯类耐药性、荚膜基因分型及相关因素
Iran J Microbiol. 2021 Apr;13(2):183-189. doi: 10.18502/ijm.v13i2.5979.
2
Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006).西班牙(1994-2006 年)耐红霉素和四环素的酿脓链球菌分离株的分子流行病学、抗菌药敏性和耐药机制。
BMC Microbiol. 2012 Sep 21;12:215. doi: 10.1186/1471-2180-12-215.
3
Molecular characterization of pneumococcal isolates from pets and laboratory animals.
宠物和实验动物分离的肺炎链球菌的分子特征。
PLoS One. 2009 Dec 14;4(12):e8286. doi: 10.1371/journal.pone.0008286.
4
Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).西班牙携带mef和mef加erm(B)的肺炎链球菌分离株的多克隆群体结构
Antimicrob Agents Chemother. 2008 Jun;52(6):1964-9. doi: 10.1128/AAC.01487-07. Epub 2008 Mar 24.
5
Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.来自欧洲的对泰利霉素不敏感的肺炎链球菌临床分离株。
Antimicrob Agents Chemother. 2006 Nov;50(11):3897-900. doi: 10.1128/AAC.00057-06.
6
Emergence of a unique multiply-antibiotic-resistant Streptococcus pneumoniae serotype 7B clone in Dhaka, Bangladesh.孟加拉国达卡出现一种独特的多重耐药肺炎链球菌7B血清型克隆株。
J Clin Microbiol. 2006 Dec;44(12):4625-7. doi: 10.1128/JCM.01740-06. Epub 2006 Sep 27.
7
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.挪威耐大环内酯类化脓性链球菌:群体结构与耐药决定因素
Antimicrob Agents Chemother. 2006 May;50(5):1896-9. doi: 10.1128/AAC.50.5.1896-1899.2006.
8
Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.德国首例耐泰利霉素肺炎链球菌分离株的分子特征分析
Antimicrob Agents Chemother. 2005 Aug;49(8):3520-2. doi: 10.1128/AAC.49.8.3520-3522.2005.
9
Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.欧洲大环内酯类耐药肺炎链球菌分离株的分子流行病学
J Clin Microbiol. 2005 Mar;43(3):1294-300. doi: 10.1128/JCM.43.3.1294-1300.2005.